Lanean...
The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis
Low molecular weight heparins (LMWHs) are now the mainstay option in the prevention and treatment of venous thromboembolism. In some patients receiving therapeutic doses of LMWH, activity can be measured by quantifying the presence of Anti-factor Xa (AFXa) for dose adjustment. However, currently the...
Gorde:
| Argitaratua izan da: | Hematol Rep |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
PAGEPress Publications, Pavia, Italy
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4691677/ https://ncbi.nlm.nih.gov/pubmed/26733269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2015.5844 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|